Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Genetic Technologies stock

Learn how to easily invest in Genetic Technologies stock.

Genetic Technologies Ltd is a diagnostics & research business based in the US. Genetic Technologies shares (GENE) are listed on the NASDAQ and all prices are listed in US Dollars. Genetic Technologies employs 52 staff and has a trailing 12-month revenue of around $9.2 million.

How to buy shares in Genetic Technologies

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GENE – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Genetic Technologies stock price (NASDAQ: GENE)

Use our graph to track the performance of GENE stocks over time.

Genetic Technologies shares at a glance

Information last updated 2022-09-25.
Latest market close$1.24
52-week range$0.95 - $3.27
50-day moving average $1.50
200-day moving average $1.66
Wall St. target price$12.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.60

Buy Genetic Technologies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Genetic Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Genetic Technologies price performance over time

Historical closes compared with the close of $1.24 from 2022-09-28

1 week (2022-09-23) -4.62%
1 month (2022-08-26) N/A
3 months (2022-06-28) -3.88%
6 months (2022-03-26) N/A
1 year (2021-09-30) -59.87%
2 years (2020-09-30) -64.16%
3 years (2019-09-30) 1.9
5 years (2017-09-29) 45.92%

Genetic Technologies financials

Revenue TTM $9.2 million
Gross profit TTM $6.2 million
Return on assets TTM -21.54%
Return on equity TTM -37.57%
Profit margin -77.36%
Book value $1.20
Market capitalisation $21.5 million

TTM: trailing 12 months

Genetic Technologies share dividends

We're not expecting Genetic Technologies to pay a dividend over the next 12 months.

Have Genetic Technologies's shares ever split?

Genetic Technologies's shares were split on a 1:4 basis on 14 August 2019. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Genetic Technologies shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Genetic Technologies shares which in turn could have impacted Genetic Technologies's share price.

Genetic Technologies share price volatility

Over the last 12 months, Genetic Technologies's shares have ranged in value from as little as $0.95 up to $3.27. A popular way to gauge a stock's volatility is its "beta".

GENE.US volatility(beta: 1.28)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Genetic Technologies's is 1.282. This would suggest that Genetic Technologies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Genetic Technologies overview

Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include colorectal cancer, ovarian cancer, prostate cancer, coronary artery, and type 2 diabetes. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom.

Frequently asked questions

What percentage of Genetic Technologies is owned by institutions?
Currently 1.44% of Genetic Technologies shares are held by institutions.
How many people work for Genetic Technologies?
Latest data suggests 52 work at Genetic Technologies.
When does the fiscal year end for Genetic Technologies?
Genetic Technologies's fiscal year ends in June.
Where is Genetic Technologies based?
Genetic Technologies's address is: 60-66 Hanover Street, Fitzroy, VIC, Australia, 3065
What is Genetic Technologies's ISIN number?
Genetic Technologies's international securities identification number is: US37185R3075
What is Genetic Technologies's CUSIP number?
Genetic Technologies's Committee on Uniform Securities Identification Procedures number is: 37185R109

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site